Stuart Chaussee & Associates, Inc. Eli Lilly & CO Transaction History
Stuart Chaussee & Associates, Inc.
- $233 Million
- Q2 2024
A detailed history of Stuart Chaussee & Associates, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Stuart Chaussee & Associates, Inc. holds 430 shares of LLY stock, worth $381,388. This represents 0.17% of its overall portfolio holdings.
Number of Shares
430
Previous 430
-0.0%
Holding current value
$381,388
Previous $334,000
16.47%
% of portfolio
0.17%
Previous 0.18%
Shares
4 transactions
Others Institutions Holding LLY
# of Institutions
3,871Shares Held
751MCall Options Held
6.34MPut Options Held
7.97M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$85.9 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.9MShares$65.5 Billion1.31% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$58.4 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$45.6 Billion31.1% of portfolio
-
State Street Corp Boston, MA33.9MShares$30 Billion1.36% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $843B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...